Imexpharm Corporation reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was VND 417,849.65 million compared to VND 256,218.76 million a year ago. Net income was VND 55,789.57 million compared to VND 31,318.99 million a year ago. Basic earnings per share from continuing operations was VND 817.1429 compared to VND 393.3333 a year ago.
For the nine months, revenue was VND 1,086,546.4 million compared to VND 870,079.98 million a year ago. Net income was VND 155,002.99 million compared to VND 122,498.99 million a year ago. Basic earnings per share from continuing operations was VND 2,064.7619 compared to VND 1,599.0476 a year ago.